A multicenter, prospective, non-interventional cohort study to evaluate the safety and treatment pattern of sodium zirconium cyclosilicate for hyperkalaemia management in real world practice in China

Trial Identifier: D9483R00001
Sponsor: AstraZeneca
NCTID:: NCT05271266
Start Date: March 2022
Primary Completion Date: December 2023
Study Completion Date: December 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Dalian, China
China Shanghai, China